Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 16/20 | 0.42 |
| ▸ | DPP8 | Q6V1X1 | 4/20 | 0.40 |
| ▸ | DPP9 | Q86TI2 | 4/20 | 0.40 |
| ▸ | PLG | P00747 | 1/20 | 0.39 |
| ▸ | PLAT | P00750 | 1/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.38 |
| ▸ | CHRM4 | P08173 | 3/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29816390 | 0.90 | CHRM2 (0.47) | DPP4DPP8DPP9CHRM2CHRM4 | |
| SCHEMBL31497251 | 0.90 | CHRM2 (0.47) | DPP4DPP8DPP9CHRM2CHRM4 | |
| SCHEMBL29816319 | 0.90 | CHRM2 (0.47) | DPP4DPP8DPP9CHRM2CHRM4 | |
| SCHEMBL29569382 | 0.82 | DPP4 (0.51) | DPP4DPP8DPP9CHRM2CHRM4 | |
| SCHEMBL4762665 | 0.82 | ACE (0.51) | DPP4DPP8DPP9 | |
| SCHEMBL3359412 | 0.81 | DPP4 (0.50) | DPP4DPP8DPP9CHRM2CHRM3 | |
| SCHEMBL3359409 | 0.81 | DPP4 (0.50) | DPP4DPP8DPP9CHRM2CHRM3 | |
| SCHEMBL31135221 | 0.81 | CHRM3 (0.42) | DPP4DPP8DPP9CHRM2CHRM4 | |
| SCHEMBL31158095 | 0.81 | CHRM3 (0.42) | DPP4DPP8DPP9CHRM2CHRM4 | |
| SCHEMBL29569595 | 0.79 | ACE (0.49) | DPP4DPP8DPP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230374112-A1 | Bioactive Collagen Peptides, Method Of Production Thereof, And Use Thereof | BDC CAPITAL INC. (CA) | 2023-11-23 | — | — | US | claimed |
| WO-2022067445-A1 | BIOACTIVE COLLAGEN PEPTIDES, METHOD OF PRODUCTION THEREOF, AND USE THEREOF | CORPORATION GENACOL CANADA INC. (CA) | 2022-04-07 | — | — | WO | claimed |
| US-20260115261-A1 | COLLAGEN PEPTIDE-BASED MEDICAMENT COMPOSITIONS AND USES THEREOF | SUSTAIN HOLDINGS LLC (US) | 2026-04-30 | — | — | US | disclosed |
| US-12551525-B2 | Collagen peptide-based medicament compositions and devices and methods of production and use thereof | SUSTAIN HOLDINGS, LLC (US) | 2026-02-17 | — | — | US | disclosed |
| WO-2025245289-A1 | INJECTABLE COMPOSITIONS FOR ACCELERATING THE PRODUCTION OF COLLAGEN-CONTAINING PROTEINS AND METHODS OF TREATMENT USING INJECTABLE COMPOSITIONS | MEEHAN KEVIN (US) | 2025-11-27 | — | — | WO | disclosed |
| US-12419936-B2 | Collagen peptide-based medicament compositions and devices and methods of production and use thereof | SUSTAIN HOLDINGS, LLC (US) | 2025-09-23 | — | — | US | disclosed |
| US-20250268974-A1 | COLLAGEN PEPTIDE-BASED MEDICAMENT COMPOSITIONS AND DEVICES AND METHODS OF PRODUCTION AND USE THEREOF | SUSTAIN HOLDINGS, LLC | 2025-08-28 | — | — | US | disclosed |
| US-20250213641-A1 | COLLAGEN PEPTIDE-BASED MEDICAMENT COMPOSITIONS AND DEVICES AND METHODS OF PRODUCTION AND USE THEREOF | SUSTAIN HOLDINGS, LLC | 2025-07-03 | — | — | US | disclosed |
| EP-4552693-A2 | COLLAGEN PEPTIDE-BASED MEDICAMENT COMPOSITIONS AND DEVICES AND METHODS OF PRODUCTION AND USE THEREOF | Sustain Holdings, LLC (US) | 2025-05-14 | — | — | EP | disclosed |
| WO-2025096630-A2 | COLLAGEN PEPTIDE-BASED MEDICAMENT COMPOSITIONS AND USES THEREOF | SUSTAIN HOLDINGS, LLC (US) | 2025-05-08 | — | — | WO | disclosed |
| US-12280086-B2 | Collagen peptide-based medicament compositions and devices and methods of production and use thereof | SUSTAIN HOLDINGS, LLC (US) | 2025-04-22 | — | — | US | disclosed |
| CN-114209880-B | Preparation method of biological composite material for orderly mineralizing polypeptide, product and application thereof | 浙江大学 | 2022-11-08 | — | — | CN | disclosed |
| US-20220280592-A1 | COLLAGEN PEPTIDE-BASED MEDICAMENT COMPOSITIONS AND DEVICES AND METHODS OF PRODUCTION AND USE THEREOF | SUSTAIN HOLDINGS LLC (US) | 2022-09-08 | — | — | US | disclosed |
| US-11433112-B1 | Collagen peptide-based medicament compositions and devices and methods of production and use thereof | SUSTAIN HOLDINGS, LLC (US) | 2022-09-06 | — | — | US | disclosed |
| US-11426440-B2 | Collagen peptide-based medicament compositions and devices and methods of production and use thereof | SUSTAIN HOLDINGS, LLC (US) | 2022-08-30 | — | — | US | disclosed |
| US-11389513-B2 | Collagen peptide-based medicament compositions and devices and methods of production and use thereof | SUSTAIN HOLDINGS, LLC (US) | 2022-07-19 | — | — | US | disclosed |
| WO-2022093107-A1 | BIOACTIVE POLYETHYLENE COPOLYMER, POLYETHYLENE MACROMOLECULE AND RELATED METHODS THEREOF | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2022-05-05 | — | — | WO | disclosed |
| WO-2022067445-A1 | BIOACTIVE COLLAGEN PEPTIDES, METHOD OF PRODUCTION THEREOF, AND USE THEREOF | CORPORATION GENACOL CANADA INC. (CA) | 2022-04-07 | — | — | WO | disclosed |
| CN-114209880-A | Preparation method of biological composite material of ordered mineralized polypeptide, product and application thereof | 浙江大学 | 2022-03-22 | — | — | CN | disclosed |
| EP-3958889-A2 | COLLAGEN PEPTIDE-BASED MEDICAMENT COMPOSITIONS AND DEVICES AND METHODS OF PRODUCTION AND USE THEREOF | Sustain Holdings, LLC (US) | 2022-03-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260115261-A1 | COLLAGEN PEPTIDE-BASED MEDICAMENT COMPOSITIONS AND USES THEREOF | COL1A1, COL2A1, COL14A1 | DPP4 852/4885DPP8 2138/4885DPP9 1537/4885 |
| US-12551525-B2 | Collagen peptide-based medicament compositions and devices and methods of production and use thereof | COL2A1, COL14A1, COL1A1 | DPP4 1566/4885DPP8 2253/4885DPP9 1166/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.